Interdisziplinäre Tumorkonferenz – Mammakarzinom nach Radiatio im Kindesalter bei Morbus Hodgkin Erkrankung

Fallbericht

In Kooperation mit dem Konsortium für familiären Brust- und Eierstockkrebs unter Federführung von Frau Prof. R.K. Schmutzler und der Studienzentrale der Therapiestudien HD-78 – HD-90 für Morbus Hodgkin (HD) bei Kindern und Jugendlichen [1] (Studienleitung Prof. G Schellong) wurde im August 2012 ein intensiviertes Brustkrebs-Früherkennungsprogramm in Anlehnung an die intensivierte Früherkennung für hereditären Brust- und Eierstockkrebs ins Leben gerufen. Das Angebot richtet sich an langzeitüberlebende HD-Patientinnen nach thorakaler Bestrahlung im Kindesalter an den Zentren des Konsortiums [2],[3],[4],[5]. Wir berichten hier über eine Patientin, die am Brustzentrum Heidelberg vorstellig wurde.

• Literatur

• 1 Schellong G. Treatment of children and adolescents with Hodgkin‘s disease: the experience of the German-Austrian Paediatric Study Group. Baillieres Clin Haematol 1996; 9: 619-34
• 2 Saslow D, Boetes C, Burke W et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57: 75-89
• 3 Meindl A, Ditsch N, Kast K et al. Hereditary breast and ovarian cancer: new genes, new treatments, new concepts. Dtsch Arztebl Int 2011; 108: 323-330
• 4 The Children’s Oncology Group. Long-Term Follow up Guidlines for Survivors of childhood, Adolesence and Young Adult Cancer (2007). Im Internet:. http://www.survivorshipguidlines.org
• 5 Nathan PC, Ness KK, Mahoney MC et al. Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Ann Intern Med 2010; 153: 442-451
• 6 Rathore B, Kadin ME. Hodgkin‘s lymphoma therapy: past, present, and future. Expert Opin Pharmacother 2010; 11 (17) 2891-2906
• 7 Ibrahim EM, Abouelkhair KM, Kazkaz GA et al. Risk of second breast cancer in female Hodgkin‘s lymphoma survivors: a meta-analysis. BMC Cancer 2012; 12: 197
• 8 Baxi SS, Matasar MJ. State-of-the-art issues in Hodgkin‘s lymphoma survivorship. Curr Oncol Rep 2010; 12: 366-373
• 9 Blaauwbroek R, Groenier KH, Kamps WA et al. Late effects in adult survivors of childhood cancer: the need for life-long follow-up. Ann Oncol 2007; 18: 1898-1902
• 10 Kremer LC, Mulder RL, Oeffinger KC et al. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: A report from the international late effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer 2013; 60: 543-549
• 11 Oeffinger KC, Hudson MM, Mertens AC et al. Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan. Pediatr Blood Cancer 2011; 56: 818-824
• 12 Oeffinger KC, Ford JS, Moskowitz CS et al. Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA 2009; 301: 404-414
• 13 Travis LB, Hill DA, Dores GM et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003; 290: 465-75
• 14 Taylor AJ, Winter DL, Stiller CA et al. Risk of breast cancer in female survivors of childhood Hodgkin‘s disease in Britain: a population-based study. Int J Cancer 2006; 120: 384-391
• 15 Kenney LB, Yasui Y, Inskip PD et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med 2004; 141: 590-597
• 16 Chaya S, Moskowitz JFC, Wolden SL et al. New insights into the risk of breast cancer in childhood cancer survivors treated with chest radiation: A report from the Childhood Cancer Survivor Study (CCSS) and the Women‘s Environmental Cancer and Radiation Epidemiology (WECARE) Study. J Clin Oncol 2012; (suppl; abstr CRA9513)
• 17 Inskip PD, Robison LL, Stovall M et al. Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol 2009; 27: 3901-3907
• 18 Bluhm EC, Ronckers C, Hayashi RJ et al. Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood 2008; 111: 4014-4021
• 19 Swerdlow AJ, Cooke R, Bates A et al. Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin‘s lymphoma in England and Wales: a National Cohort Study. J Clin Oncol 2012; 30: 2745-2752
• 20 Basu SK, Schwartz Fisher SG. et al. Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin‘s disease. Int J Radiat Oncol Biol Phys 2008; 72 (1) 34-40
• 21 http://www.krebshilfe.de/Brustkrebszentren.html